BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36792768)

  • 1. Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes.
    Toesca DAS; Susko M; von Eyben R; Baclay JRM; Pollom EL; Jeffrey RB; Poullos PD; Poultsides GA; Fisher GA; Visser BC; Koong AC; Feng M; Chang DT
    Ann Surg Oncol; 2023 Jun; 30(6):3479-3488. PubMed ID: 36792768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Pancreatic Cancer Resectability and Outcomes Based on an Objective Quantitative Scoring System.
    Toesca DAS; Jeffrey RB; von Eyben R; Pollom EL; Poullos PD; Poultsides GA; Fisher GA; Visser BC; Koong AC; Chang DT
    Pancreas; 2019; 48(5):622-628. PubMed ID: 31091207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations.
    Manak E; Merkel S; Klein P; Papadopoulos T; Bautz WA; Baum U
    Abdom Imaging; 2009; 34(1):75-80. PubMed ID: 17934772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDCT in Pancreatic adenocarcinoma: prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations.
    Vargas R; Nino-Murcia M; Trueblood W; Jeffrey RB
    AJR Am J Roentgenol; 2004 Feb; 182(2):419-25. PubMed ID: 14736675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: a challenge for MDCT.
    Morgan DE; Waggoner CN; Canon CL; Lockhart ME; Fineberg NS; Posey JA; Vickers SM
    AJR Am J Roentgenol; 2010 Mar; 194(3):615-22. PubMed ID: 20173136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
    Jang JK; Byun JH; Kang JH; Son JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Kim SC; Lee MG
    Eur Radiol; 2021 Feb; 31(2):813-823. PubMed ID: 32845389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy.
    Noda Y; Pisuchpen N; Mercaldo ND; Sekigami Y; Michelakos T; Parakh A; Wo JY; Qadan M; Ferrone C; Lillemoe KD; Ryan DP; Clark JW; Fernandez-Del Castillo C; Hong TS; Kambadakone AR
    Eur Radiol; 2022 Apr; 32(4):2470-2480. PubMed ID: 34665317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy.
    Cassinotto C; Mouries A; Lafourcade JP; Terrebonne E; Belleannée G; Blanc JF; Lapuyade B; Vendrely V; Laurent C; Chiche L; Wagner T; Sa-Cunha A; Gaye D; Trillaud H; Laurent F; Montaudon M
    Radiology; 2014 Oct; 273(1):108-16. PubMed ID: 24960211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting resectability of pancreatic head cancer with multi-detector CT. Surgical and pathologic correlation.
    Olivié D; Lepanto L; Billiard JS; Audet P; Lavallée JM
    JOP; 2007 Nov; 8(6):753-8. PubMed ID: 17993727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative CT staging of borderline pancreatic cancer patients after neoadjuvant treatment: accuracy in the prediction of vascular invasion and resectability.
    Ahmed SA; Mourad AF; Hassan RA; Ibrahim MAE; Soliman A; Aboeleuon E; Elbadee OMA; Hetta HF; Jabir MA
    Abdom Radiol (NY); 2021 Jan; 46(1):280-289. PubMed ID: 32488556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
    Mortensen MB
    Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of multi-detector computerized tomography scan, endoscopic ultrasound, and laparoscopy for predicting tumor resectability in pancreatic adenocarcinoma.
    Baghbanian M; Salmanroghani H; Baghbanian A; Bakhtpour M; Shabazkhani B
    Indian J Gastroenterol; 2013 Nov; 32(6):376-80. PubMed ID: 23982702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease.
    Cassinotto C; Dohan A; Zogopoulos G; Chiche L; Laurent C; Sa-Cunha A; Cuggia A; Reinhold C; Gallix B
    Eur J Radiol; 2017 Oct; 95():33-38. PubMed ID: 28987689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: Results from a prospective, multicentre phase 2 trial (NEOLAP-AIO-PAK-0113).
    Guggenberger KV; Bley TA; Held S; Keller R; Flemming S; Wiegering A; Germer CT; Kimmel B; Kunzmann V; Hartlapp I; Anger F
    Eur J Radiol; 2023 Jun; 163():110834. PubMed ID: 37080059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Vascular Invasion Using a 3-Point Scale Computed Tomography Grading System in Pancreatic Ductal Adenocarcinoma: Correlation With Surgery.
    Zhang L; Zhang ZY; Ni JM; Li B; Chen FM; Jiang CJ; Hu CH
    J Comput Assist Tomogr; 2017; 41(3):394-400. PubMed ID: 27798447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
    Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
    Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Cancer CT: Prediction of Resectability according to NCCN Criteria.
    Hong SB; Lee SS; Kim JH; Kim HJ; Byun JH; Hong SM; Song KB; Kim SC
    Radiology; 2018 Dec; 289(3):710-718. PubMed ID: 30251929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.
    Garces-Descovich A; Beker K; Jaramillo-Cardoso A; James Moser A; Mortele KJ
    Abdom Radiol (NY); 2018 Feb; 43(2):314-322. PubMed ID: 29392370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
    Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
    Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.